Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at ...

The latest announcement is out from Novavax ( (NVAX) ).

Novavax Inc said on Monday it ended the third quarter with $334.2 million in cash and cash equivalents, as it prepares to start a delayed U.S.-based late-stage trial of its COVID-19 vaccine candidate ...

Next-generation vaccines enhance immunization with precision-targeted immune responses, transforming public health and addressing global health challenges.

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

One of Novavax’s largest shareholders is again putting pressure on the Gaithersburg vaccine maker — this time, to consider a ...

Novavax (NVAX) stock is in focus as the company assign its Gaithersburg facility to AstraZeneca (AZN) in a deal worth nearly ...

Novavax, Inc. (Nasdaq: NVAX) today announced that it has further executed against its planned transformation into a lean, ...

U.S. drug developer Novavax Inc said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, ...

A Truth Social post shared by President Donald Trump on Sept. 26 provided multiple pieces of vaccine advice that do not align with his administration’s recent recommendations, potentially creating ...

Novel approach could apply to multiple types of allergy, including food allergies, and may become an alternative to routine allergy shots CINCINNATI, Sept. 23, 2025 /PRNewswire/ -- A vaccine that uses ...